GW Pharmaceuticals Plc ADS (GWPH)

[Tanis2476]

So let’s see. Beats estimates and is thissss close to being profitable. If 2nd quarter is flat as was stated on the earnings call, and assuming most commercial expenditures are drastically reduced for all of Q2 (at least in the US), then I expect the company becomes profitable in Q2.

Next, drug was descheduled at a federal level, waiting on states to follow and payers will likely lessen coverage restrictions at the very least with refills.

Next TSC approval by end of July “effectively doubling patient popultation” for approved indications.

Next Sativex is a pipeline in a drug, but sounds like trial enrollment is delayed until 2nd half 2020. Fine.

Sure there will be volatility over next several months due to world events, but damn, this is a great long term hold with an eventual buy out.

GLTA